Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 9Lung Neoplasms 5Myeloproliferative Disorders 4Leukemia, Myelomonocytic, Chronic 4Sarcoma 3Prostatic Neoplasms 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Breast Neoplasms 3Stomatitis 2Primary Myelofibrosis 2Neoplasm Metastasis 2Multiple Myeloma 2Mucositis 2Melanoma 2Lymphoma, Non-Hodgkin 2Leukemia, Monocytic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Disease 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Synovial 1Prostate Cancer Metastatic 1Polycythemia Vera 1

Interventions

ulixertinib 1tislelizumab 1talazoparib 1serabelisib 1sapanisertib 1pembrolizumab 1olaparib 1mirdametinib 1lenvatinib 1erdafitinib 1crenigacestat 1atezolizumab 1Ramucirumab 1Paclitaxel 1PM 01183 1Injections 1IFL protocol 1Gemcitabine 1Bosentan 1BID protein, human 1Appointments and Schedules 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Solid Tumor × Injections × Clear all
NCT05109442 2025-08-20

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

Affimed GmbH

Phase 1/2 Terminated
112 enrolled 28 charts
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡